Searched for
LEE PHARMA
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Shriram Properties appoints Ravindra Kumar Pandey as Chief Financial OfficerShriram Properties Ltd announced Ravindra Kumar Pandey as the new CFO from August 14, 2024, succeeding Gopalakrishnan J, now the Group CEO....
- Sensex falls! But these stocks are up over 10% on BSEIn the Nifty 50 index, 7 stocks were trading in the green, while 43 stocks were trading in the red.
- Indian API segment sees PE, strategic inflow nearly doubling in 2021Three private equity– led investment platforms have been created specifically targeting the API space, while at least half a dozen transact...
- Seo Jung-jin: Founder who needed loan sharks is now South Korea’s second richestHis rise is extraordinary and represents a shift in the country’s business elite. While family-run conglomerates touch almost every aspect ...
- Confused whether to invest in stocks at market peaks? Listen to Bruce LeeMost market experts believe the domestic equity market is in a multi-year bull run.
- Two generics makers end battle to copy drugs amid patent debateBoth companies, BDR Pharma and Lee Pharma, had been seeking so-called compulsory licenses that override patents and allow generics firms in...
- India rejects compulsory license application of Lee Pharma against AstraZeneca’s SaxagliptinThe Indian Patent Office has rejected the application of Lee Pharma for a compulsory license on AstraZeneca’s anti-diabetes drug saxaglipti...
- India rejects licence plea for AstraZeneca's anti-diabetic drugThe Indian patent office has rejected Hyderabad-based Lee Pharma's application for a compulsory licence on AstraZeneca's anti-diabetic medi...
- Repaired SpaceX rocket to fly by early December, company saysSpace Exploration Technologies, or SpaceX, expects to return a repaired and upgraded Falcon 9 rocket to flight around the start of December...
- India rejects Lee Pharma’s compulsory licence pleaIndia has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca’s key antidiabetes compound Saxagliptin.
- Taiwanese machine tools makers keen to expand in IndiaTaiwanese companies, notably those from the machine tool industry, are firming up plans to invest in manufacturing facilities in the countr...
- High Court rejects AstraZeneca’s diabetes drug pleaThe Delhi High Court has dismissed AstraZeneca’s plea to block Hyderabadbased Lee Pharma from making copies of its anti-diabetes drug Ongly...
- Lee Pharma wants licence for AstraZeneca's diabetes drugLee Pharma filed the application on June 29 to make a generic version of the patented drug, marketed as Onglyza, under Section 84 of the Pa...
- Alibaba’s Jack Ma is second richest Asian, overtakes Mukesh AmbaniMa (50), a former English teacher, has overtaken Mukesh Ambani and Hong Kong's Lee Shau Kee. He now boasts of a personal wealth of $26.5 bi...
- Singapore seeks Indian IT, pharma investments: OfficialSingapore-based institutes are undertaking advanced levels of medical researches which would support Indian pharma companies' global market...
- Brokers' call on Aurobindo Pharma, Hindalco, IndiaIn its report, BNP analysts said they will remain bearish on Indian policy options before the next elections in 2014, and a drop in growth ...
- HUL, Garnier, Nivea, Emami vie for pie of men’s grooming marketAnshul D can tell the difference between a mohawk styled with hair wax and another spiked with gel.
- Singapore invites Indian investments in pharma, solar energySingapore has invited Indian businesses to collaborate with its local players in sectors like solar power, pharmaceutical and chemicals.
- 'The Indian story is yet to be told'Ahead of the summit, W Lee Howell spells out his priorities as head of WEF in India.
Load More
